South Korea Pharmaceuticals

Icure Pharmaceutical Inc (175250)

Track

Track

Icure Pharmaceutical Inc. recorded seven insider trading transactions over the past ninety days, all representing buy orders. Three individuals, including directors Ahn Young Kyun and Choi Young Jong, acquired shares totaling 10,517,980 KRW. No sell activity occurred during this period, and the company has not released a recent earnings report.
Ticker: 175250 Exchange: KOE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kim, Seongsu (김성수) Director (이사) Director
Transaction date
Purchase
Price
483.82
Quantity 33,619 +36.3%
Value ₩4,632,390
CHA YUN SANG (차윤상) Unclassified position (상무) Officer
Transaction date
Purchase
Price
344.26
Quantity 18,536 +38.6%
Value ₩1,893,813
CHA YUN SANG (차윤상) Unclassified position (상무) Officer
Transaction date
Purchase
Price
427.52
Quantity 76,072 -30.4%
Value ₩80,574
CHA YUN SANG (차윤상) Unclassified position (상무) Officer
Transaction date
Purchase
Price
1,909.00
Quantity 1,000 +60.0%
Value ₩100,000
Ahn Young Kyun (안영균) Director (이사) Director
Transaction date
Purchase
Price
1,854.00
Quantity 1,000 +81.8%
Value ₩100,000
Choi Young Jong (최영종) Director (이사) Director
Transaction date
Purchase
Price
1,920.00
Quantity 1,000
Value ₩100,000
CHA YUN SANG (차윤상) Unclassified position (상무) Officer
Transaction date
Purchase
Price
2,740.00
Quantity 1,000
Value ₩100,000
Ahn Young Kyun (안영균) Director (이사) Director
Transaction date
Purchase
Price
2,454.00
Quantity 1,000
Value ₩100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-15 2026-09-11 B Purchase Kim, Seongsu (김성수)

Director (이사)

Director
33,619 +36.3%
483.82
₩4,632,390 		33,619 +36.3% 483.82 ₩4,632,390
2026-09-10 2026-09-10 B Purchase CHA YUN SANG (차윤상)

Unclassified position (상무)

Officer
18,536 +38.6%
344.26
₩1,893,813 		18,536 +38.6% 344.26 ₩1,893,813
2026-09-10 2026-09-09 B Purchase CHA YUN SANG (차윤상)

Unclassified position (상무)

Officer
76,072 -30.4%
427.52
₩80,574 		76,072 -30.4% 427.52 ₩80,574
2026-09-10 2026-09-08 B Purchase CHA YUN SANG (차윤상)

Unclassified position (상무)

Officer
1,000 +60.0%
1,909.00
₩100,000 		1,000 +60.0% 1,909.00 ₩100,000
2026-09-09 2026-09-08 B Purchase Ahn Young Kyun (안영균)

Director (이사)

Director
1,000 +81.8%
1,854.00
₩100,000 		1,000 +81.8% 1,854.00 ₩100,000
2026-09-09 2026-09-08 B Purchase Choi Young Jong (최영종)

Director (이사)

Director
1,000
1,920.00
₩100,000 		1,000 1,920.00 ₩100,000
2026-09-10 2026-09-07 B Purchase CHA YUN SANG (차윤상)

Unclassified position (상무)

Officer
1,000
2,740.00
₩100,000 		1,000 2,740.00 ₩100,000
2026-09-09 2026-09-07 B Purchase Ahn Young Kyun (안영균)

Director (이사)

Director
1,000
2,454.00
₩100,000 		1,000 2,454.00 ₩100,000
Explore more

More insider trading research around Icure Pharmaceutical Inc

More insider trades in South Korea
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific